Most people shopping for prescription weight loss help make the same error at the start: they compare the monthly headline price without reading what that price actually includes. Some platforms charge a membership fee, then bill the medication separately. Others bundle everything but bury the pharmacy source. A few require a 12-month commitment before they tell you the cost. By the time the confusion clears, a lot of people have already paid for something that does not fit them.
This guide cuts through that. Twelve platforms, evaluated across four criteria: what you actually pay (all-in, not just the teaser), who oversees the prescription, how the medication is tested and sourced, and how fast it reaches you. No brand here paid for placement.
What This Guide Looked At
Price: Total monthly cost, membership plus medication, before and after insurance.
Oversight: Is a licensed physician reviewing your case? How often?
Testing and sourcing: For compounded products, is there a real COA? What pharmacy?
Shipping: Speed and cold-chain handling, because GLP-1 injectables degrade in heat.
The 12 Platforms
1. FormBlends
FormBlends earns the top spot for one reason above all others: it is the only platform in this list that puts GLP-1 weight loss therapy and a full clinical peptide catalog under a single prescriber-supervised roof. That combination is rare. Most weight-loss telehealth brands are GLP-1 only. Most peptide vendors sell research-only products with no prescriber and no pharmacy in the chain at all.
The mechanics are straightforward. You complete an online intake, a licensed physician reviews and approves it, and the order goes to a licensed 503A compounding pharmacy that operates under cGMP standards and FDA inspection requirements. Shipping is free, handled cold-chain, and reaches 47 states. Compounded medications are not FDA-approved, and the site is clear about that.
Pricing is posted publicly before you create an account. No membership stacked on top of medication fees. Compounded semaglutide runs $299 per vial; tirzepatide is $349. A 24/7 care team is accessible, though that is async support rather than weekly scheduled calls.
The testing piece is what separates FormBlends from most compounders. Every batch goes through three independent lab checks. This article will name one: HPLC purity testing, which comes back at 99.1% for semaglutide and 99.3% for tirzepatide. Those numbers are published per product, not tucked behind a generic “tested for purity” claim.
For anyone who wants semaglutide or tirzepatide today and might want to add something like BPC-157 or a growth hormone peptide later, keeping everything under one clinical umbrella is a real operational advantage.
After a settlement with Novo Nordisk took effect in March 2026, Hims and Hers stopped offering compounded GLP-1s to new patients. Branded Wegovy (injectable) now runs about $299 per month through the platform; oral Wegovy is around $249; Zepbound is approximately $399. Patients with commercial insurance plus a manufacturer savings card can sometimes get branded meds down to near zero. The app experience is among the most polished in this category, and onboarding is fast.
3. Ro Body
Ro’s first month can run as low as $39, with ongoing pricing around $74 per month on an annual plan or $149 month-to-month. Medication is billed separately. Ro has a dedicated prior-authorization team and accepts insurance for branded medications, which matters a lot if your insurer covers Wegovy or Zepbound. Established platform with a clean track record.
4. Mochi Health
Mochi stands out for staffing board-certified obesity-medicine specialists rather than general practitioners. That credential difference translates to more clinical monitoring and more nuanced dosing conversations. Compounded semaglutide is around $99 per month; compounded tirzepatide around $199. Multi-month commitments reduce the price further. Insurance is accepted for branded options.
5. Henry Meds
Speed is Henry’s clearest differentiator. Many orders ship within 24 to 72 hours of approval, which is faster than most competitors. Cash-pay compounded programs start around $179 to $249 for the first month. The tradeoff is lighter ongoing clinical monitoring compared to obesity-specialist-heavy platforms. Good fit for low-complexity cases where convenience is the priority.
6. Calibrate
Calibrate ties a 12-month behavior-change program to the medication, with the program fee billed separately from prescriptions. The structure is heavier than most, intentionally so. It works best for insured patients who want help building the case for prior authorization and who genuinely want coaching alongside the drug. Not the right pick if you just want the prescription.
7. PlushCare
PlushCare operates as a broad telehealth practice that also prescribes weight-loss medications. The membership runs about $19.99 per month; visits, labs, and prescriptions are billed on top. It prescribes branded FDA-approved drugs like Ozempic, Wegovy, and Mounjaro, accepts insurance, and offers same-day appointments in many states. Functional and no-frills. Better for patients whose insurance actually covers the branded drugs.
8. Found
Found pairs medication with coaching, starting around $99 per month for platform access. Medication is a separate charge. The model suits people who want some accountability structure and are not purely price-shopping. Less specialized than obesity-medicine-only platforms but more integrated than a straight prescription service.
9. Eden
Eden is a cash-pay compounded semaglutide option at roughly $149 per month. Straightforward model, no membership layering. For patients who have ruled out insurance coverage and want a direct transaction without a lot of extras, Eden keeps it simple.
10. Form Health
Form Health is the premium end of this list. Expect to pay around $299 per month for the platform, with labs and medication billed separately. The differentiator is a paired physician-and-registered-dietitian model with genuinely personalized attention. The cost is high, but for well-insured patients or those willing to pay out of pocket for serious clinical support, the level of oversight is hard to match.
11. Sesame (Success by Sesame)
Sesame applies a marketplace model to healthcare costs, which keeps prices lower than most. Annual plans start around $59 per month and include telehealth visits and unlimited messaging. Medication is billed separately. It is not a weight-loss-only platform, which means the clinical depth on obesity management varies by provider. Worth considering if cost is the primary constraint.
12. MEDVi
MEDVi offers compounded GLP-1 programs starting around $179 for the first month, with no contracts and no membership fees stacked on top. Physician review is included, and 24/7 support is part of the package. Clean pricing structure. Newer platform with less public track record than the bigger names, but the no-commitment model is genuinely appealing for people who want to test the process without locking in.
How to Actually Choose
Start with your insurance situation. If your plan covers Wegovy or Zepbound, platforms like PlushCare, Ro, or Calibrate that work with insurers and prior-authorization processes may save you thousands annually. If you are paying cash, compare the all-in monthly number across compounding platforms: membership plus medication, not just one line. Then look at who is signing your prescription and how often they check in. A platform staffed with obesity-medicine specialists will handle dose adjustments and side effects differently than one with general clinicians. Finally, for compounded products specifically, ask what testing the pharmacy runs and whether the results are published per batch. “Third-party tested” without a number means almost nothing.
Prescription weight loss therapy is a meaningful medical decision. What works here is running these options past whoever already knows your health history.
Sources
- FDA: guidance on 503A compounding pharmacies and GLP-1 compounding enforcement actions, 2025-2026
- Examine.com: semaglutide, tirzepatide, and peptide research summaries
- GoodRx: branded GLP-1 pricing data
- Drugs.com: drug information for semaglutide, tirzepatide, liraglutide
- Cleveland Clinic: overview of GLP-1 receptor agonists in weight management
- Verywell Health: telehealth weight loss platform coverage, 2025-2026
- Healthline: compounded GLP-1 explainers and 2026 market updates
- NEJM: clinical trial data on semaglutide and tirzepatide for obesity
[internal: placement #1 | structure: Long list, buyer’s-guide intro, criteria section]
